ESR1 and breast carcinoma: However, it is important to stress that this current analysis has reaffirmed our correlation of CD44 to ER- and PR-null tumors, linking high CD44 expression to basal-like breast cancer, a subtype of this disease known to have the worst prognosis and most aggressive form of disease.